These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30765635)

  • 21. Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?
    Herchenhorn D; Ferreira CG
    J Clin Oncol; 2011 Apr; 29(10):e283-4; author reply e285-7. PubMed ID: 21300921
    [No Abstract]   [Full Text] [Related]  

  • 22. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Awada A; Ismael G
    Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A
    Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The never-ending story: finding a role for neoadjuvant chemotherapy in the management of head and neck cancer.
    Garden AS
    J Clin Oncol; 2014 Sep; 32(25):2685-6. PubMed ID: 25049324
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.
    Posner MR; Colevas AD; Tishler RB
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):13-24. PubMed ID: 10952434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of cis-platinum and 5-fluorouracil as induction chemotherapy prior to radiation therapy in advanced head and neck cancer.
    Thongprasert S; Lorvidhaya V; Sumitsawan Y; Tonusin A; Phandphae P; Changwaiwit W; Chaimongkol B
    J Med Assoc Thai; 1988 Nov; 71(11):602-4. PubMed ID: 3221145
    [No Abstract]   [Full Text] [Related]  

  • 29. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
    Bernier J; Vrieling C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does DeCIDE give a decisive answer against induction chemotherapy in head and neck cancers?
    Chakraborty S; Patil VM
    J Clin Oncol; 2015 Mar; 33(8):967. PubMed ID: 25667296
    [No Abstract]   [Full Text] [Related]  

  • 31. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
    Ohashi T; Ohnishi M; Tanahashi S; Murai M
    Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemo re-irradiation in recurrent head and neck cancer: a single institution experience.
    Katodritis N; Charalampous H; Vomvas D
    J BUON; 2012; 17(2):397. PubMed ID: 22740226
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic chemotherapy for squamous cell head and neck cancer.
    Adelstein DJ
    Expert Opin Pharmacother; 2003 Dec; 4(12):2151-63. PubMed ID: 14640914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current concepts for the management of head and neck cancer: chemotherapy.
    Specenier PM; Vermorken JB
    Oral Oncol; 2009; 45(4-5):409-15. PubMed ID: 18715812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy of head and neck cancer.
    Nwizu T; Adelstein D
    Expert Opin Pharmacother; 2015; 16(16):2409-22. PubMed ID: 26513647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation.
    Mantovani G; Maccio A; Massa E; Mulas C; Mudu MC; Massidda S; Massa D; Murgia V; Ferreli L; Succu G; Astara G; Proto E; Tore G; Mura M; Maxia G
    Int J Oncol; 2000 Jun; 16(6):1227-33. PubMed ID: 10812000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current role of systemic chemotherapy in the primary treatment of head and neck cancer.
    Busch CJ; Tribius S; Schafhausen P; Knecht R
    Cancer Treat Rev; 2015 Mar; 41(3):217-21. PubMed ID: 25687982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.